| scholarly article | Q13442814 |
| P2093 | author name string | Hanna Taipaleenmäki | |
| Marie-Therese Haider | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
| MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression | Q24683830 | ||
| MicroRNAs and Osteolytic Bone Metastasis: The Roles of MicroRNAs in Tumor-Induced Osteoclast Differentiation | Q26783571 | ||
| Targeting the Wnt pathways for therapies | Q26821978 | ||
| Megakaryocytes, malignancy and bone marrow vascular niches | Q26862087 | ||
| T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer | Q27311542 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| Impact of Bone-Targeted Treatments on Skeletal Morbidity and Survival in Breast Cancer | Q28075195 | ||
| Tumour-derived miRNAs and bone metastasis | Q28086895 | ||
| Putting tumours in context | Q28207789 | ||
| miRBase: annotating high confidence microRNAs using deep sequencing data | Q28660701 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| A multigenic program mediating breast cancer metastasis to bone | Q29614308 | ||
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| Metastasis to bone: causes, consequences and therapeutic opportunities | Q29614310 | ||
| The distribution of secondary growths in cancer of the breast. 1889 | Q29614314 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
| miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. | Q30407836 | ||
| Systemic endocrine instigation of indolent tumor growth requires osteopontin | Q33343851 | ||
| MicroRNAs in the control of metastatic bone disease | Q33821326 | ||
| Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis | Q34024176 | ||
| Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors | Q34152009 | ||
| Metastatic bone disease: role of transcription factors and future targets | Q34217531 | ||
| A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells | Q34240754 | ||
| Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells | Q34281856 | ||
| miR-214 targets ATF4 to inhibit bone formation. | Q34316430 | ||
| Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor | Q34480347 | ||
| Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer | Q34644776 | ||
| Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow | Q34755120 | ||
| Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. | Q52867416 | ||
| Mechanisms of bone metastasis | Q84730325 | ||
| Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation | Q37956245 | ||
| New therapeutic targets for cancer bone metastasis | Q38473066 | ||
| Bone Metastasis-Related MicroRNAs: New Targets for Treatment? | Q38539474 | ||
| Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy. | Q38581768 | ||
| The role of microRNAs in bone metastasis | Q38808905 | ||
| Bone metastasis: the importance of the neighbourhood. | Q38843253 | ||
| Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver | Q38873616 | ||
| miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. | Q39018734 | ||
| Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo | Q39352902 | ||
| Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases? | Q40366096 | ||
| Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function | Q40736018 | ||
| The role of biomarkers in the management of bone-homing malignancies. | Q41692580 | ||
| Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites | Q41761675 | ||
| Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone | Q41881171 | ||
| MicroRNAs as regulators of tumor-associated stromal cells | Q42506714 | ||
| Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study | Q42829926 | ||
| Distinct bone marrow blood vessels differentially regulate haematopoiesis. | Q46564265 | ||
| Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy | Q47302520 | ||
| Regulation of Bone Metabolism by microRNAs | Q47730978 | ||
| MicroRNAs and Cancer: A Long Story for Short RNAs | Q47839947 | ||
| Manipulating the environment of cancer cells in bone: a novel therapeutic approach | Q34826767 | ||
| The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells | Q35079440 | ||
| Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. | Q35203556 | ||
| Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease | Q35251618 | ||
| PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target | Q35578573 | ||
| VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors | Q35621527 | ||
| Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives | Q35744492 | ||
| The Role of Osteoclasts in Early Dissemination of Prostate Cancer Tumor Cells. | Q35747744 | ||
| Dissecting the metastatic cascade | Q35788115 | ||
| Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche | Q35976918 | ||
| MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review | Q36037933 | ||
| miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway | Q36192032 | ||
| Breast Cancer Cell Colonization of the Human Bone Marrow Adipose Tissue Niche | Q36397005 | ||
| miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells | Q36451980 | ||
| Osteocyte control of osteoclastogenesis | Q36514172 | ||
| Osteoblastic activation in the hematopoietic stem cell niche. | Q36532592 | ||
| Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo. | Q36621024 | ||
| MicroRNA control of bone formation and homeostasis | Q36661323 | ||
| Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation | Q36674531 | ||
| Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. | Q36682092 | ||
| Bone marrow cells in the 'pre-metastatic niche': within bone and beyond | Q36691234 | ||
| Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT. | Q36731080 | ||
| Cancer to bone: a fatal attraction | Q36884628 | ||
| The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites | Q37096553 | ||
| The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. | Q37126990 | ||
| MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma | Q37175182 | ||
| WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth | Q37277156 | ||
| The perivascular niche regulates breast tumour dormancy. | Q37305997 | ||
| Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis | Q37322289 | ||
| Bone targeted treatments in cancer - The story so far | Q37337487 | ||
| Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer | Q37575983 | ||
| Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells. | Q37684242 | ||
| Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells | Q37694746 | ||
| Dysregulation of developmental pathways in bone metastasis | Q37772654 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 202 | |
| P577 | publication date | 2018-04-27 | |
| P1433 | published in | Frontiers in Endocrinology | Q27723680 |
| P1476 | title | Targeting the Metastatic Bone Microenvironment by MicroRNAs. | |
| P478 | volume | 9 |
| Q64992109 | A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer. |
| Q90655998 | Brain metastasis-related microRNAs in patients with advanced breast cancer |
| Q91782750 | Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment |
| Q92945435 | Inhibition of CRY2 by STAT3/miRNA-7-5p Promotes Osteoblast Differentiation through Upregulation of CLOCK/BMAL1/P300 Expression |
| Q92582088 | MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2 |
| Q97426733 | Tumor dormancy in bone |
| Q61804483 | miR-135a suppresses migration of gastric cancer cells by targeting TRAF5-mediated NF-κB activation |
Search more.